SlideShare une entreprise Scribd logo
1  sur  10
Percutaneous Ablation of Hepatocellular
Carcinoma: Current Status
Justin P. McWilliams, MD, Shota Yamamoto, BS, Steven S. Raman, MD, Christopher T. Loh, MD,
  Edward W. Lee, MD, David M. Liu, MD, and Stephen T. Kee, MD


Hepatocellular carcinoma (HCC) is an increasingly common disease with dismal long-term survival. Percutaneous
ablation has gained popularity as a minimally invasive, potentially curative therapy for HCC in nonoperative
candidates. The seminal technique of percutaneous ethanol injection has been largely supplanted by newer modal-
ities, including radiofrequency ablation, microwave ablation, cryoablation, and high-intensity focused ultrasound
ablation. A review of these modalities, including technical success, survival rates, and complications, will be
presented, as well as considerations for treatment planning and follow-up.

J Vasc Interv Radiol 2010; 21:S204 –S213

Abbreviations:    HCC ϭ hepatocellular carcinoma, PEI ϭ percutaneous ethanol injection, RF ϭ radiofrequency



HEPATOCELLULAR carcinoma (HCC)                               During the past few decades, several        all patients to define the size and number
is now the fifth most common cancer,                     minimally invasive ablation techniques          of tumors, their location, and their rela-
and the third leading cause of cancer                    have been developed to prolong the “sur-        tionship to vital structures.
death worldwide (1). Although hepatic                    vivability” of unresectable HCC. Percuta-           At our institution, treatment decisions
resection remains a first-line treatment,                neous ethanol injection was introduced as       for hepatocellular carcinoma are made in
approximately 80% of patients are not                    the seminal ablation technique for HCC in       the setting of a multidisciplinary tumor
candidates as a result of poor hepatic                   the 1980s. In 1990, the first use of percuta-   board, including representatives from on-
reserve, tumor location, or tumor bur-                   neous radiofrequency (RF) ablation for          cology, hepatology, abdominal and inter-
den (2), and eventual tumor recurrence                   HCC was published (7), followed by per-         ventional radiology, surgery, and radia-
is the rule (3). Orthotopic liver trans-                 cutaneous microwave (MW) ablation in            tion oncology. Percutaneous ablation is
plantation offers high rates of disease-                 1994 (8). More recently, cold-based and         the preferred mode of treatment for non-
free remission (4), but is limited by strin-             extracorporeal techniques have also been        surgical candidates with one or several
gent selection criteria, cost, and donor                 introduced (Fig). Ablation can offer po-        tumors up to 3 cm, or up to 5 cm in select
availability (5). Overall 5-year survival                tentially curative treatment for small (Ͻ 3     situations. Once referred for ablative ther-
rates for HCC remain lower than 10% in                   cm) and medium-sized (3–5 cm) HCC,              apy, all patients are seen in clinic with the
Europe and the United States (6).                        can salvage cases of tumor recurrence,          interventionist, at which time a history
                                                         and can “bridge” patients to orthotopic         and physical is performed, the risks and
                                                         liver transplantation by prolonging sur-        benefits of the procedure are discussed,
                                                         vivability and decreasing tumor burden          and visibility of the tumor on ultrasound
From the Departments of Interventional Radiology
(J.P.M., C.T.L., D.M.L., S.T.K.) and Radiological Sci-
                                                         (9–12).                                         is confirmed.
ences (S.Y., E.W.L.), University of California Los           In this review, we discuss the percuta-         Durable success of ablation, and re-
Angeles Medical Center, 757 Westwood Plaza, Suite        neous ablative therapies for local control      sultant improved survival, depends on
2125C, Los Angeles, CA 90095; Department of Radi-        of HCC, with a focus on survival data,          complete ablation of the tumor (13,14).
ology, Faculty of Medicine (D.M.L.), University of       recurrence rates, and complications.
British Columbia; and Department of Radiology,                                                           The likelihood of complete ablation de-
Interventional Radiology Section (D.M.L.), Van-                                                          creases with increasing tumor size (14 –
couver General Hospital, Vancouver, British Co-                                                          16), and multiplicity of tumors com-
lumbia, Canada. Received October 7, 2009; final          TREATMENT PLANNING
                                                                                                         pounds this consideration. Transarterial
revision received October 28, 2009; accepted No-
vember 7, 2009. Address correspondence to J.P.M.;           The use of biomarkers and surveil-           chemoembolization, systemic chemo-
E-mail: jumcwilliams@mednet.ucla.edu                     lance imaging with ultrasound (US), com-        therapy, or symptomatic treatment can
                                                         puted tomography (CT), and magnetic             be considered if the tumor burden is
None of the authors have identified a conflict of
interest.                                                resonance (MR) imaging has facilitated          deemed excessive or unsafe for ablation.
                                                         the early detection of HCC (12). Mul-               The approach to the tumor should
© SIR, 2010
                                                         tiphase contrast-enhanced CT or MR im-          avoid crossing other organs, large vessels,
DOI: 10.1016/j.jvir.2009.11.025                          aging of the liver should be performed in       and major bile ducts. With the use of US,


S204
Volume 21     Number 8S                                                                               McWilliams et al        •   S205


                                                                                             RF Ablation
                                                                                                RF ablation uses rapidly alternating
                                                                                             RF current to induce frictional heat
                                                                                             around an electrode, producing cell
                                                                                             death by coagulation necrosis. Small
                                                                                             electrode diameter, good ablation area
                                                                                             size, and effective marketing have com-
                                                                                             bined to make RF ablation a popular
                                                                                             technique. RF ablation also benefits
                                                                                             from the “oven effect”; heat retention is
                                                                                             improved in lesions surrounded by cir-
                                                                                             rhotic tissue (35). Complete ablation
                                                                                             rates for small to medium HCC exceed
                                                                                             80% in a single treatment session, and
                                                                                             exceed 90% with two sessions; 5-year
                                                                                             survival rates in the largest studies are
                                                                                             40%–58% (14,18,19,36 –39). Local pro-
                                                                                             gression after complete ablation is un-
                                                                                             commonly observed (1%–12%). RF abla-
                                                                                             tion studies are summarized in Table 1
                                                                                             (18,19,36 –38).
Figure. Representative percutaneous ablation devices. Clockwise from top left: Cool-Tip         The most commonly used RF abla-
internally cooled RF electrode, LeVeen expandable RF electrodes, Evident 915-MHz             tion devices in contemporary practice
cooled-shaft percutaneous MW antenna, and Perc-24 cryoprobe (Endocare, Irvine, Cali-         are monopolar internally cooled
fornia). (Available in color online at www.jvir.org.)                                        electrodes, such as the Cool-Tip de-
                                                                                             vice (Covidien, Mansfield, Massa-
                                                                                             chusetts), and monopolar multitined
some obliquity can usually be found that       ous ethanol injection (PEI). Several non-     expandable electrodes, such as the
will allow safe placement of the ablation      randomized trials in the 1990s (25–27)        LeVeen (Boston Scientific, Natick, Mas-
probe. CT-ultrasound fusion imaging,           confirmed that PEI can safely achieve         sachusetts) or RITA (Angiodynamics,
which matches a preprocedural volumet-         complete necrosis of small HCCs, with         Queensbury, New York) devices. Two
ric CT to real-time ultrasound images, can     5-year survival rates of 32%–38%. How-        studies have been performed compar-
aid probe placement in difficult cases (17).   ever, the technique suffered from the need    ing the effectiveness of the two electrode
Positioning of the active tip near the large   for multiple treatment sessions, uncer-       types in the treatment of small HCC
and small bowel, bile ducts, stomach, gall-    tainty of the ablation zone, and a high       (40,41); neither study found any differ-
bladder, and diaphragm can cause collat-       local progression rate of 17%–38% (28,29).    ence in immediate treatment success,
eral damage and limits percutaneous ab-            Several randomized controlled trials      complication rate, local progression, or
lation in approximately 6–9% of cases          compared PEI versus RF ablation in the        overall survival between the treatment
(18,19).                                       treatment of small HCC (30–32). These         groups (40,41).
    In such cases, adjunctive use of dex-                                                       Cohort studies of RF ablation have
                                               trials demonstrated an approximately
trose solution (20), carbon dioxide                                                          shown low rates of major complications,
                                               20% advantage for RF ablation versus PEI
(21), or balloon interposition (22) can                                                      ranging from 0.9% to 5.0%. (37,42). Peri-
                                               in overall survival at 3–4 years, mainly as
separate and protect vital organs.                                                           toneal hemorrhage, bile duct injury, ab-
                                               a result of a much lower incidence of local   scess, and intestinal perforation were
Thermocouples can be used to moni-
                                               tumor recurrence in the RF ablation           the most notable adverse outcomes.
tor temperatures adjacent to sensitive
                                               group. Also, approximately threefold             Tumor seeding is occasionally re-
structures (23). For lesions adjacent to
main bile ducts, the placement of a            fewer treatment sessions were required        ported, particularly with subcapsular
nasobiliary stent with instillation of         for RF ablation compared with PEI. Two        tumors, but rarely occurs when careful
chilled saline can protect the ducts           recent metaanalyses comparing RF abla-        attention is given to technique (indi-
from thermal damage (24). These tech-          tion versus PEI echoed these sentiments,      rect tumor puncture, gradual increase
niques allow the vast majority of abla-        declaring RF ablation superior to PEI in      in power deposition, and thermocoag-
tions to be safely and effectively per-        the treatment of small HCC (33,34).           ulation of the needle track) (43).
formed using percutaneous technique.               PEI maintains the advantage of al-           RF ablation does have some disad-
                                               lowing treatment of tumors near sensi-        vantages. The majority of ablation oc-
                                               tive organs and tissues, and avoids the       curs through thermal conduction, which
HCC TREATMENT                                  problem of the “heat-sink” effect adja-       can be limited by tissue desiccation and
MODALITIES                                     cent to vessels. The applicability of PEI     charring (44). RF ablation is susceptible
Percutaneous Ethanol Injection                 in other situations is limited. Given the     to a heat-sink effect from flowing blood,
                                               superiority of RF ablation to PEI for the     which may result in sublethal tempera-
   One of the first methods devised to         treatment of HCC, this review will focus      tures adjacent to vessels larger than 3
ablate liver tumors involved percutane-        on thermal ablation.                          mm in size (45– 48). As a result of elec-
S206   •   Percutaneous Ablation of HCC                                                                                        August 2010    JVIR



 Table 1
 Percutaneous RF Ablation in de novo HCC among Cohort Studies with at Least 100 Patients and 5-year Survival Data
 (18,19,36 –38)
                                                      Tumor Size                                    Survival
                                                        (cm)           Complete                       (%)             Local           Major
                              No. of   Child Class                     Ablation       No. of                        Recurrence     Complications
       Study, Year             Pts.     (A/B/C)      Mean    Range       (%)         Sessions       3y        5y       (%)             (%)
 Lencioni et al, 2005 (18)     187      144/43/0      2.8    1.5–5.0      90           1.2†         71        48        10              2
 N’Kontchou et al,             235      205/30/0      2.9    1.1–5.0      94           1.2†         60        40        12              0.9
   2005 (36)
 Tateishi et al, 2005 (37)     319*     221/94/4     2.6     0.8–9.7      93           1–2          78        54           2            4
 Raut et al, 2005 (38)         140      59/46/35     3.0       NR         97           1            74        58           3            5
 Livraghi et al, 2008 (19)     218      218/0/0      NR        Յ2         98           1.1†         76        55           1            2
 Note.—NR ϭ not reported.
 * A total of 137 of these patients received transarterial embolization before RF ablation. Tumor size, technical success rate, local
 recurrence rate, and major complication rate are composite data from de novo and recurrent HCC in this series.
 † Mean.


 Table 2
 Details of Percutaneous Microwave Ablation in HCC among Cohort Studies with at Least 50 Patients (51–53)
                                                                                              Survival
                                                      Tumor Size (cm)      Complete             (%)                  Local            Major
                             No. of    Child Class                         Ablation                                Recurrence      Complications
      Study, Year             Pts.      (A/B/C)       Mean      Range        (%)              3y         5y           (%)              (%)
 Dong et al, 2003 (51)        234      24/207/3        4.1      1.2–8.0        89*            66         57           7%               0%
 Liang et al, 2005 (52)       288      54/214/20       3.8      1.2–8.0        NR             72         51           8%               NR
 Lu et al, 2001 (53)           50      16/30/4         2.7      0.8–6.4        94†            73         —            6%               0%
 Note.—NR ϭ not reported.
 * One session.
 † Two sessions.



tromagnetic interference, only one RF          nae can be simultaneously activated                 series showed no difference in complete
electrode can be activated at one time,        with MW ablation, potentially allowing              ablation rate or survival between the
which can lengthen procedure time in           more rapid treatment of large or multi-             two techniques in HCC averaging 2.6
medium and large lesions. Finally, the         focal tumors (50). Grounding pads are               cm in size, despite worse underlying
grounding pads required for RF abla-           not required.                                       liver disease and more tumor multiplic-
tion can occasionally cause skin burns.           Three cohort studies of percutaneous             ity in the MW ablation group (55). In
These limitations have invited interest        MW ablation in a mix of small to large              contrast, a second unmatched series
in alternative ablation modalities de-         HCC demonstrated a complete ablation                in small HCC showed better survival in
scribed in the subsequent sections.            rate of 89%–94%, local progression rate             the RF ablation group (71% vs 49% at 3
                                               of 6%– 8%, and 5-year survival rate of              years), largely due to higher complica-
Microwave Ablation                             51%–57%, despite a predominance of                  tion and local recurrence rates with MW
                                               patients with Child class B disease (51–            ablation (56).
    Microwave (MW) ablation uses high-         53). These results compare favorably                   The range of complications encoun-
frequency electromagnetic energy to ag-        with the results of RF ablation (Table 2)           tered with MW ablation are the same as
itate water molecules, producing frictional    (51–53).                                            with RF ablation, including hemor-
heat and resultant coagulation necrosis.          One randomized controlled trial (54)             rhage, abscess, biliary tract injury, and
Although both modalities function by           compared MW ablation versus RF abla-                tumor seeding. The rate of major com-
tissue heating, MW ablation has several        tion for small HCC in 72 well matched               plication in most series varies from 0%
advantages versus RF ablation. MW ab-          patients. The complete ablation rates               to 8%, similar to RF ablation.
lation has a much broader zone of active       were similar (89% for MW and 96% for                   The above-quoted studies of percuta-
heating, leading to higher temperatures        RF). Long-term survival was not re-                 neous MW ablation come from Asia, us-
within the targeted zone in a shorter          ported.                                             ing a previous-generation 2450-MHz
treatment time. The active heating of             The only comparative survival data               microwave system. A new generation of
MW ablation is less affected by the heat-      for MW versus RF ablation with percu-               cooled-shaft 2450-MHz antennae prom-
sink effect, improving tumor necrosis          taneous technique come from retrospec-              ise ablation volumes similar to the lat-
adjacent to vessels (49). Multiple anten-      tive, unmatched case series. One such               est-generation RF ablation electrodes
My article
My article
My article
My article
My article
My article
My article

Contenu connexe

Tendances

External Beam Radiotherapy for Hepatocellular carcinoma
External Beam Radiotherapy for Hepatocellular carcinomaExternal Beam Radiotherapy for Hepatocellular carcinoma
External Beam Radiotherapy for Hepatocellular carcinomaBala Vellayappan
 
Durham ir approaches
Durham ir approachesDurham ir approaches
Durham ir approachesIsha Rabani
 
ROLE OF RADIATION IN BONE TUMORS FOR ORTHOPEDICS
ROLE OF RADIATION IN BONE TUMORS FOR ORTHOPEDICSROLE OF RADIATION IN BONE TUMORS FOR ORTHOPEDICS
ROLE OF RADIATION IN BONE TUMORS FOR ORTHOPEDICSKanhu Charan
 
Sarcoma brachytherapy updates
Sarcoma brachytherapy updatesSarcoma brachytherapy updates
Sarcoma brachytherapy updatesAshutosh Mukherji
 
STOMACH CANCER PANEL DISCUSSION
STOMACH CANCER PANEL DISCUSSIONSTOMACH CANCER PANEL DISCUSSION
STOMACH CANCER PANEL DISCUSSIONKanhu Charan
 
Principles of radiotherapy in gastric carcinoma
Principles of radiotherapy in gastric carcinomaPrinciples of radiotherapy in gastric carcinoma
Principles of radiotherapy in gastric carcinomaAnil Gupta
 
Radiotherapy in lymphoma(dr fadavi)-001
Radiotherapy in lymphoma(dr fadavi)-001Radiotherapy in lymphoma(dr fadavi)-001
Radiotherapy in lymphoma(dr fadavi)-001pedramfadavi
 
Infield and outfield nodal recurrence cervix
Infield and outfield nodal recurrence cervixInfield and outfield nodal recurrence cervix
Infield and outfield nodal recurrence cervixKanhu Charan
 
St gallen rectal carcinoma
St gallen rectal carcinomaSt gallen rectal carcinoma
St gallen rectal carcinomaParag Roy
 
Patterns of failure and treatment related toxicity in EFRT IN CA CERVIX
Patterns of failure and treatment related toxicity in EFRT IN CA CERVIXPatterns of failure and treatment related toxicity in EFRT IN CA CERVIX
Patterns of failure and treatment related toxicity in EFRT IN CA CERVIXradiation oncology
 
TARGET DELINEATION OF CANCER ESOPHAGUS
TARGET DELINEATION OF CANCER ESOPHAGUSTARGET DELINEATION OF CANCER ESOPHAGUS
TARGET DELINEATION OF CANCER ESOPHAGUSKanhu Charan
 
cours chimioembolisation CHC dec 2014
cours chimioembolisation CHC dec 2014cours chimioembolisation CHC dec 2014
cours chimioembolisation CHC dec 2014Dr Sameh AWAD
 
Radiotherapy in carcinoma rectum
Radiotherapy in carcinoma rectumRadiotherapy in carcinoma rectum
Radiotherapy in carcinoma rectumSagar Raut
 
Cytoreductive nephrectomy (when and why)
Cytoreductive nephrectomy (when and why)Cytoreductive nephrectomy (when and why)
Cytoreductive nephrectomy (when and why)Ahmad Kharrouby
 
Rectal cancer Preoperative Radiotherapy- Short vs long course
Rectal cancer Preoperative Radiotherapy- Short vs long courseRectal cancer Preoperative Radiotherapy- Short vs long course
Rectal cancer Preoperative Radiotherapy- Short vs long courseGaurav Kumar
 

Tendances (20)

External Beam Radiotherapy for Hepatocellular carcinoma
External Beam Radiotherapy for Hepatocellular carcinomaExternal Beam Radiotherapy for Hepatocellular carcinoma
External Beam Radiotherapy for Hepatocellular carcinoma
 
Durham ir approaches
Durham ir approachesDurham ir approaches
Durham ir approaches
 
Contouring rectal cancers
Contouring rectal cancersContouring rectal cancers
Contouring rectal cancers
 
ROLE OF RADIATION IN BONE TUMORS FOR ORTHOPEDICS
ROLE OF RADIATION IN BONE TUMORS FOR ORTHOPEDICSROLE OF RADIATION IN BONE TUMORS FOR ORTHOPEDICS
ROLE OF RADIATION IN BONE TUMORS FOR ORTHOPEDICS
 
Sarcoma brachytherapy updates
Sarcoma brachytherapy updatesSarcoma brachytherapy updates
Sarcoma brachytherapy updates
 
STOMACH CANCER PANEL DISCUSSION
STOMACH CANCER PANEL DISCUSSIONSTOMACH CANCER PANEL DISCUSSION
STOMACH CANCER PANEL DISCUSSION
 
Cytoreductive nephrectomy
Cytoreductive nephrectomyCytoreductive nephrectomy
Cytoreductive nephrectomy
 
Principles of radiotherapy in gastric carcinoma
Principles of radiotherapy in gastric carcinomaPrinciples of radiotherapy in gastric carcinoma
Principles of radiotherapy in gastric carcinoma
 
Radiotherapy in lymphoma(dr fadavi)-001
Radiotherapy in lymphoma(dr fadavi)-001Radiotherapy in lymphoma(dr fadavi)-001
Radiotherapy in lymphoma(dr fadavi)-001
 
Infield and outfield nodal recurrence cervix
Infield and outfield nodal recurrence cervixInfield and outfield nodal recurrence cervix
Infield and outfield nodal recurrence cervix
 
St gallen rectal carcinoma
St gallen rectal carcinomaSt gallen rectal carcinoma
St gallen rectal carcinoma
 
Patterns of failure and treatment related toxicity in EFRT IN CA CERVIX
Patterns of failure and treatment related toxicity in EFRT IN CA CERVIXPatterns of failure and treatment related toxicity in EFRT IN CA CERVIX
Patterns of failure and treatment related toxicity in EFRT IN CA CERVIX
 
TARGET DELINEATION OF CANCER ESOPHAGUS
TARGET DELINEATION OF CANCER ESOPHAGUSTARGET DELINEATION OF CANCER ESOPHAGUS
TARGET DELINEATION OF CANCER ESOPHAGUS
 
cours chimioembolisation CHC dec 2014
cours chimioembolisation CHC dec 2014cours chimioembolisation CHC dec 2014
cours chimioembolisation CHC dec 2014
 
Radiotherapy in carcinoma rectum
Radiotherapy in carcinoma rectumRadiotherapy in carcinoma rectum
Radiotherapy in carcinoma rectum
 
Crc rt updates ethiopia
Crc rt updates   ethiopiaCrc rt updates   ethiopia
Crc rt updates ethiopia
 
Bone metastasis
Bone metastasisBone metastasis
Bone metastasis
 
Cytoreductive nephrectomy (when and why)
Cytoreductive nephrectomy (when and why)Cytoreductive nephrectomy (when and why)
Cytoreductive nephrectomy (when and why)
 
Rectal cancer pacc 16
Rectal cancer pacc 16Rectal cancer pacc 16
Rectal cancer pacc 16
 
Rectal cancer Preoperative Radiotherapy- Short vs long course
Rectal cancer Preoperative Radiotherapy- Short vs long courseRectal cancer Preoperative Radiotherapy- Short vs long course
Rectal cancer Preoperative Radiotherapy- Short vs long course
 

Similaire à My article

Thermal Ablation of Renal Tumors under Ultrasound Guidance and Conscious Seda...
Thermal Ablation of Renal Tumors under Ultrasound Guidance and Conscious Seda...Thermal Ablation of Renal Tumors under Ultrasound Guidance and Conscious Seda...
Thermal Ablation of Renal Tumors under Ultrasound Guidance and Conscious Seda...asclepiuspdfs
 
BOOK ON REIRRADIATION
BOOK ON REIRRADIATIONBOOK ON REIRRADIATION
BOOK ON REIRRADIATIONKanhu Charan
 
NON SURGICAL MANAGEMENT OF HEPATOCELLULAR CARCINOMA1.pptx
NON SURGICAL MANAGEMENT OF HEPATOCELLULAR CARCINOMA1.pptxNON SURGICAL MANAGEMENT OF HEPATOCELLULAR CARCINOMA1.pptx
NON SURGICAL MANAGEMENT OF HEPATOCELLULAR CARCINOMA1.pptxAadarsh Kavoram
 
Sacral chordoma
Sacral chordomaSacral chordoma
Sacral chordomaNora Essam
 
Acs0534 Segmental Colon Resection 2006
Acs0534 Segmental Colon Resection 2006Acs0534 Segmental Colon Resection 2006
Acs0534 Segmental Colon Resection 2006medbookonline
 
Radiation induced sarcomas in head and neck
Radiation induced sarcomas in head and neckRadiation induced sarcomas in head and neck
Radiation induced sarcomas in head and neckSheh Rawat
 
2013 poggi anticancer research mw ablation of hcc using a new percutaneous de...
2013 poggi anticancer research mw ablation of hcc using a new percutaneous de...2013 poggi anticancer research mw ablation of hcc using a new percutaneous de...
2013 poggi anticancer research mw ablation of hcc using a new percutaneous de...Marco Zaccaria
 
Raditherapy4idiots
Raditherapy4idiotsRaditherapy4idiots
Raditherapy4idiotsNHS
 
RE-IRRADIATION IN HEAD AND NECK CANCER
RE-IRRADIATION IN HEAD AND NECK CANCERRE-IRRADIATION IN HEAD AND NECK CANCER
RE-IRRADIATION IN HEAD AND NECK CANCERMUNEER khalam
 
retro-peritonealsarcoma-1705061450(1).pdf
retro-peritonealsarcoma-1705061450(1).pdfretro-peritonealsarcoma-1705061450(1).pdf
retro-peritonealsarcoma-1705061450(1).pdfLolaWoo
 
EWINGS SARCOMA & RADIOTHERAPY
EWINGS SARCOMA & RADIOTHERAPYEWINGS SARCOMA & RADIOTHERAPY
EWINGS SARCOMA & RADIOTHERAPYPaul George
 
Radiotherapy and chemotherapy in Oral cancer management
Radiotherapy and chemotherapy in Oral cancer managementRadiotherapy and chemotherapy in Oral cancer management
Radiotherapy and chemotherapy in Oral cancer managementTejaswini Pss
 
Melanoma and radiation video slides
Melanoma and radiation video slidesMelanoma and radiation video slides
Melanoma and radiation video slidesRobert J Miller MD
 
Role and risk of radiation in management of.pptx
Role and risk of radiation in management of.pptxRole and risk of radiation in management of.pptx
Role and risk of radiation in management of.pptxkarpal xyngh
 
Digital version thesis Salvage for radiorecurrent prostate cancer, Max Peters
Digital version thesis Salvage for radiorecurrent prostate cancer, Max PetersDigital version thesis Salvage for radiorecurrent prostate cancer, Max Peters
Digital version thesis Salvage for radiorecurrent prostate cancer, Max PetersMax Peters
 
Role of radiation in carcinoma rectum and colon
Role of radiation in carcinoma rectum and colon Role of radiation in carcinoma rectum and colon
Role of radiation in carcinoma rectum and colon Bharti Devnani
 

Similaire à My article (20)

21
2121
21
 
Thermal Ablation of Renal Tumors under Ultrasound Guidance and Conscious Seda...
Thermal Ablation of Renal Tumors under Ultrasound Guidance and Conscious Seda...Thermal Ablation of Renal Tumors under Ultrasound Guidance and Conscious Seda...
Thermal Ablation of Renal Tumors under Ultrasound Guidance and Conscious Seda...
 
RT in Bone Tumors
RT in Bone TumorsRT in Bone Tumors
RT in Bone Tumors
 
BOOK ON REIRRADIATION
BOOK ON REIRRADIATIONBOOK ON REIRRADIATION
BOOK ON REIRRADIATION
 
NON SURGICAL MANAGEMENT OF HEPATOCELLULAR CARCINOMA1.pptx
NON SURGICAL MANAGEMENT OF HEPATOCELLULAR CARCINOMA1.pptxNON SURGICAL MANAGEMENT OF HEPATOCELLULAR CARCINOMA1.pptx
NON SURGICAL MANAGEMENT OF HEPATOCELLULAR CARCINOMA1.pptx
 
Sacral chordoma
Sacral chordomaSacral chordoma
Sacral chordoma
 
Acs0534 Segmental Colon Resection 2006
Acs0534 Segmental Colon Resection 2006Acs0534 Segmental Colon Resection 2006
Acs0534 Segmental Colon Resection 2006
 
Radiation induced sarcomas in head and neck
Radiation induced sarcomas in head and neckRadiation induced sarcomas in head and neck
Radiation induced sarcomas in head and neck
 
2013 poggi anticancer research mw ablation of hcc using a new percutaneous de...
2013 poggi anticancer research mw ablation of hcc using a new percutaneous de...2013 poggi anticancer research mw ablation of hcc using a new percutaneous de...
2013 poggi anticancer research mw ablation of hcc using a new percutaneous de...
 
Ewings Sarcoma
Ewings SarcomaEwings Sarcoma
Ewings Sarcoma
 
Raditherapy4idiots
Raditherapy4idiotsRaditherapy4idiots
Raditherapy4idiots
 
RE-IRRADIATION IN HEAD AND NECK CANCER
RE-IRRADIATION IN HEAD AND NECK CANCERRE-IRRADIATION IN HEAD AND NECK CANCER
RE-IRRADIATION IN HEAD AND NECK CANCER
 
retro-peritonealsarcoma-1705061450(1).pdf
retro-peritonealsarcoma-1705061450(1).pdfretro-peritonealsarcoma-1705061450(1).pdf
retro-peritonealsarcoma-1705061450(1).pdf
 
Retro peritoneal sarcoma
Retro peritoneal sarcomaRetro peritoneal sarcoma
Retro peritoneal sarcoma
 
EWINGS SARCOMA & RADIOTHERAPY
EWINGS SARCOMA & RADIOTHERAPYEWINGS SARCOMA & RADIOTHERAPY
EWINGS SARCOMA & RADIOTHERAPY
 
Radiotherapy and chemotherapy in Oral cancer management
Radiotherapy and chemotherapy in Oral cancer managementRadiotherapy and chemotherapy in Oral cancer management
Radiotherapy and chemotherapy in Oral cancer management
 
Melanoma and radiation video slides
Melanoma and radiation video slidesMelanoma and radiation video slides
Melanoma and radiation video slides
 
Role and risk of radiation in management of.pptx
Role and risk of radiation in management of.pptxRole and risk of radiation in management of.pptx
Role and risk of radiation in management of.pptx
 
Digital version thesis Salvage for radiorecurrent prostate cancer, Max Peters
Digital version thesis Salvage for radiorecurrent prostate cancer, Max PetersDigital version thesis Salvage for radiorecurrent prostate cancer, Max Peters
Digital version thesis Salvage for radiorecurrent prostate cancer, Max Peters
 
Role of radiation in carcinoma rectum and colon
Role of radiation in carcinoma rectum and colon Role of radiation in carcinoma rectum and colon
Role of radiation in carcinoma rectum and colon
 

Plus de pryce27

Intro to interventional radiology
Intro to interventional radiologyIntro to interventional radiology
Intro to interventional radiologypryce27
 
Rsna final 2
Rsna final 2Rsna final 2
Rsna final 2pryce27
 
Liver cancer final3
Liver cancer final3Liver cancer final3
Liver cancer final3pryce27
 
Gi fellows talk g tubes and gi bleeding
Gi fellows talk   g tubes and gi bleedingGi fellows talk   g tubes and gi bleeding
Gi fellows talk g tubes and gi bleedingpryce27
 
Hh tposter revised final
Hh tposter revised finalHh tposter revised final
Hh tposter revised finalpryce27
 
Hepatic arterial anatomy and vascular optimization final
Hepatic arterial anatomy and vascular optimization finalHepatic arterial anatomy and vascular optimization final
Hepatic arterial anatomy and vascular optimization finalpryce27
 
Applications of ir in obstetrics and gynecology2
Applications of ir in obstetrics and gynecology2Applications of ir in obstetrics and gynecology2
Applications of ir in obstetrics and gynecology2pryce27
 
Life saving embolizations
Life saving embolizationsLife saving embolizations
Life saving embolizationspryce27
 
Workshop book for sir 2012 justin
Workshop book for sir 2012 justinWorkshop book for sir 2012 justin
Workshop book for sir 2012 justinpryce27
 
Poster renal biopsy
Poster renal biopsyPoster renal biopsy
Poster renal biopsypryce27
 
Hht poster (1)
Hht poster (1)Hht poster (1)
Hht poster (1)pryce27
 
Ba sic ir interventions
Ba sic ir interventionsBa sic ir interventions
Ba sic ir interventionspryce27
 
Clinical management of ir patients in gonda
Clinical management of ir patients in gondaClinical management of ir patients in gonda
Clinical management of ir patients in gondapryce27
 
Radiation
RadiationRadiation
Radiationpryce27
 
Liver manifestations of hht revised
Liver manifestations of hht revisedLiver manifestations of hht revised
Liver manifestations of hht revisedpryce27
 
Renal transplant biopsy
Renal transplant biopsyRenal transplant biopsy
Renal transplant biopsypryce27
 
Endovascular therapy - device based review
Endovascular therapy - device based reviewEndovascular therapy - device based review
Endovascular therapy - device based reviewpryce27
 

Plus de pryce27 (19)

Intro to interventional radiology
Intro to interventional radiologyIntro to interventional radiology
Intro to interventional radiology
 
Rsna final 2
Rsna final 2Rsna final 2
Rsna final 2
 
Liver cancer final3
Liver cancer final3Liver cancer final3
Liver cancer final3
 
Gi fellows talk g tubes and gi bleeding
Gi fellows talk   g tubes and gi bleedingGi fellows talk   g tubes and gi bleeding
Gi fellows talk g tubes and gi bleeding
 
Hh tposter revised final
Hh tposter revised finalHh tposter revised final
Hh tposter revised final
 
Hepatic arterial anatomy and vascular optimization final
Hepatic arterial anatomy and vascular optimization finalHepatic arterial anatomy and vascular optimization final
Hepatic arterial anatomy and vascular optimization final
 
Applications of ir in obstetrics and gynecology2
Applications of ir in obstetrics and gynecology2Applications of ir in obstetrics and gynecology2
Applications of ir in obstetrics and gynecology2
 
Life saving embolizations
Life saving embolizationsLife saving embolizations
Life saving embolizations
 
Workshop book for sir 2012 justin
Workshop book for sir 2012 justinWorkshop book for sir 2012 justin
Workshop book for sir 2012 justin
 
Poster renal biopsy
Poster renal biopsyPoster renal biopsy
Poster renal biopsy
 
Hht poster (1)
Hht poster (1)Hht poster (1)
Hht poster (1)
 
Pe
PePe
Pe
 
Ba sic ir interventions
Ba sic ir interventionsBa sic ir interventions
Ba sic ir interventions
 
Clinical management of ir patients in gonda
Clinical management of ir patients in gondaClinical management of ir patients in gonda
Clinical management of ir patients in gonda
 
Radiation
RadiationRadiation
Radiation
 
Liver manifestations of hht revised
Liver manifestations of hht revisedLiver manifestations of hht revised
Liver manifestations of hht revised
 
Pae 5
Pae 5Pae 5
Pae 5
 
Renal transplant biopsy
Renal transplant biopsyRenal transplant biopsy
Renal transplant biopsy
 
Endovascular therapy - device based review
Endovascular therapy - device based reviewEndovascular therapy - device based review
Endovascular therapy - device based review
 

My article

  • 1. Percutaneous Ablation of Hepatocellular Carcinoma: Current Status Justin P. McWilliams, MD, Shota Yamamoto, BS, Steven S. Raman, MD, Christopher T. Loh, MD, Edward W. Lee, MD, David M. Liu, MD, and Stephen T. Kee, MD Hepatocellular carcinoma (HCC) is an increasingly common disease with dismal long-term survival. Percutaneous ablation has gained popularity as a minimally invasive, potentially curative therapy for HCC in nonoperative candidates. The seminal technique of percutaneous ethanol injection has been largely supplanted by newer modal- ities, including radiofrequency ablation, microwave ablation, cryoablation, and high-intensity focused ultrasound ablation. A review of these modalities, including technical success, survival rates, and complications, will be presented, as well as considerations for treatment planning and follow-up. J Vasc Interv Radiol 2010; 21:S204 –S213 Abbreviations: HCC ϭ hepatocellular carcinoma, PEI ϭ percutaneous ethanol injection, RF ϭ radiofrequency HEPATOCELLULAR carcinoma (HCC) During the past few decades, several all patients to define the size and number is now the fifth most common cancer, minimally invasive ablation techniques of tumors, their location, and their rela- and the third leading cause of cancer have been developed to prolong the “sur- tionship to vital structures. death worldwide (1). Although hepatic vivability” of unresectable HCC. Percuta- At our institution, treatment decisions resection remains a first-line treatment, neous ethanol injection was introduced as for hepatocellular carcinoma are made in approximately 80% of patients are not the seminal ablation technique for HCC in the setting of a multidisciplinary tumor candidates as a result of poor hepatic the 1980s. In 1990, the first use of percuta- board, including representatives from on- reserve, tumor location, or tumor bur- neous radiofrequency (RF) ablation for cology, hepatology, abdominal and inter- den (2), and eventual tumor recurrence HCC was published (7), followed by per- ventional radiology, surgery, and radia- is the rule (3). Orthotopic liver trans- cutaneous microwave (MW) ablation in tion oncology. Percutaneous ablation is plantation offers high rates of disease- 1994 (8). More recently, cold-based and the preferred mode of treatment for non- free remission (4), but is limited by strin- extracorporeal techniques have also been surgical candidates with one or several gent selection criteria, cost, and donor introduced (Fig). Ablation can offer po- tumors up to 3 cm, or up to 5 cm in select availability (5). Overall 5-year survival tentially curative treatment for small (Ͻ 3 situations. Once referred for ablative ther- rates for HCC remain lower than 10% in cm) and medium-sized (3–5 cm) HCC, apy, all patients are seen in clinic with the Europe and the United States (6). can salvage cases of tumor recurrence, interventionist, at which time a history and can “bridge” patients to orthotopic and physical is performed, the risks and liver transplantation by prolonging sur- benefits of the procedure are discussed, vivability and decreasing tumor burden and visibility of the tumor on ultrasound From the Departments of Interventional Radiology (J.P.M., C.T.L., D.M.L., S.T.K.) and Radiological Sci- (9–12). is confirmed. ences (S.Y., E.W.L.), University of California Los In this review, we discuss the percuta- Durable success of ablation, and re- Angeles Medical Center, 757 Westwood Plaza, Suite neous ablative therapies for local control sultant improved survival, depends on 2125C, Los Angeles, CA 90095; Department of Radi- of HCC, with a focus on survival data, complete ablation of the tumor (13,14). ology, Faculty of Medicine (D.M.L.), University of recurrence rates, and complications. British Columbia; and Department of Radiology, The likelihood of complete ablation de- Interventional Radiology Section (D.M.L.), Van- creases with increasing tumor size (14 – couver General Hospital, Vancouver, British Co- 16), and multiplicity of tumors com- lumbia, Canada. Received October 7, 2009; final TREATMENT PLANNING pounds this consideration. Transarterial revision received October 28, 2009; accepted No- vember 7, 2009. Address correspondence to J.P.M.; The use of biomarkers and surveil- chemoembolization, systemic chemo- E-mail: jumcwilliams@mednet.ucla.edu lance imaging with ultrasound (US), com- therapy, or symptomatic treatment can puted tomography (CT), and magnetic be considered if the tumor burden is None of the authors have identified a conflict of interest. resonance (MR) imaging has facilitated deemed excessive or unsafe for ablation. the early detection of HCC (12). Mul- The approach to the tumor should © SIR, 2010 tiphase contrast-enhanced CT or MR im- avoid crossing other organs, large vessels, DOI: 10.1016/j.jvir.2009.11.025 aging of the liver should be performed in and major bile ducts. With the use of US, S204
  • 2. Volume 21 Number 8S McWilliams et al • S205 RF Ablation RF ablation uses rapidly alternating RF current to induce frictional heat around an electrode, producing cell death by coagulation necrosis. Small electrode diameter, good ablation area size, and effective marketing have com- bined to make RF ablation a popular technique. RF ablation also benefits from the “oven effect”; heat retention is improved in lesions surrounded by cir- rhotic tissue (35). Complete ablation rates for small to medium HCC exceed 80% in a single treatment session, and exceed 90% with two sessions; 5-year survival rates in the largest studies are 40%–58% (14,18,19,36 –39). Local pro- gression after complete ablation is un- commonly observed (1%–12%). RF abla- tion studies are summarized in Table 1 (18,19,36 –38). Figure. Representative percutaneous ablation devices. Clockwise from top left: Cool-Tip The most commonly used RF abla- internally cooled RF electrode, LeVeen expandable RF electrodes, Evident 915-MHz tion devices in contemporary practice cooled-shaft percutaneous MW antenna, and Perc-24 cryoprobe (Endocare, Irvine, Cali- are monopolar internally cooled fornia). (Available in color online at www.jvir.org.) electrodes, such as the Cool-Tip de- vice (Covidien, Mansfield, Massa- chusetts), and monopolar multitined some obliquity can usually be found that ous ethanol injection (PEI). Several non- expandable electrodes, such as the will allow safe placement of the ablation randomized trials in the 1990s (25–27) LeVeen (Boston Scientific, Natick, Mas- probe. CT-ultrasound fusion imaging, confirmed that PEI can safely achieve sachusetts) or RITA (Angiodynamics, which matches a preprocedural volumet- complete necrosis of small HCCs, with Queensbury, New York) devices. Two ric CT to real-time ultrasound images, can 5-year survival rates of 32%–38%. How- studies have been performed compar- aid probe placement in difficult cases (17). ever, the technique suffered from the need ing the effectiveness of the two electrode Positioning of the active tip near the large for multiple treatment sessions, uncer- types in the treatment of small HCC and small bowel, bile ducts, stomach, gall- tainty of the ablation zone, and a high (40,41); neither study found any differ- bladder, and diaphragm can cause collat- local progression rate of 17%–38% (28,29). ence in immediate treatment success, eral damage and limits percutaneous ab- Several randomized controlled trials complication rate, local progression, or lation in approximately 6–9% of cases compared PEI versus RF ablation in the overall survival between the treatment (18,19). treatment of small HCC (30–32). These groups (40,41). In such cases, adjunctive use of dex- Cohort studies of RF ablation have trials demonstrated an approximately trose solution (20), carbon dioxide shown low rates of major complications, 20% advantage for RF ablation versus PEI (21), or balloon interposition (22) can ranging from 0.9% to 5.0%. (37,42). Peri- in overall survival at 3–4 years, mainly as separate and protect vital organs. toneal hemorrhage, bile duct injury, ab- a result of a much lower incidence of local scess, and intestinal perforation were Thermocouples can be used to moni- tumor recurrence in the RF ablation the most notable adverse outcomes. tor temperatures adjacent to sensitive group. Also, approximately threefold Tumor seeding is occasionally re- structures (23). For lesions adjacent to main bile ducts, the placement of a fewer treatment sessions were required ported, particularly with subcapsular nasobiliary stent with instillation of for RF ablation compared with PEI. Two tumors, but rarely occurs when careful chilled saline can protect the ducts recent metaanalyses comparing RF abla- attention is given to technique (indi- from thermal damage (24). These tech- tion versus PEI echoed these sentiments, rect tumor puncture, gradual increase niques allow the vast majority of abla- declaring RF ablation superior to PEI in in power deposition, and thermocoag- tions to be safely and effectively per- the treatment of small HCC (33,34). ulation of the needle track) (43). formed using percutaneous technique. PEI maintains the advantage of al- RF ablation does have some disad- lowing treatment of tumors near sensi- vantages. The majority of ablation oc- tive organs and tissues, and avoids the curs through thermal conduction, which HCC TREATMENT problem of the “heat-sink” effect adja- can be limited by tissue desiccation and MODALITIES cent to vessels. The applicability of PEI charring (44). RF ablation is susceptible Percutaneous Ethanol Injection in other situations is limited. Given the to a heat-sink effect from flowing blood, superiority of RF ablation to PEI for the which may result in sublethal tempera- One of the first methods devised to treatment of HCC, this review will focus tures adjacent to vessels larger than 3 ablate liver tumors involved percutane- on thermal ablation. mm in size (45– 48). As a result of elec-
  • 3. S206 • Percutaneous Ablation of HCC August 2010 JVIR Table 1 Percutaneous RF Ablation in de novo HCC among Cohort Studies with at Least 100 Patients and 5-year Survival Data (18,19,36 –38) Tumor Size Survival (cm) Complete (%) Local Major No. of Child Class Ablation No. of Recurrence Complications Study, Year Pts. (A/B/C) Mean Range (%) Sessions 3y 5y (%) (%) Lencioni et al, 2005 (18) 187 144/43/0 2.8 1.5–5.0 90 1.2† 71 48 10 2 N’Kontchou et al, 235 205/30/0 2.9 1.1–5.0 94 1.2† 60 40 12 0.9 2005 (36) Tateishi et al, 2005 (37) 319* 221/94/4 2.6 0.8–9.7 93 1–2 78 54 2 4 Raut et al, 2005 (38) 140 59/46/35 3.0 NR 97 1 74 58 3 5 Livraghi et al, 2008 (19) 218 218/0/0 NR Յ2 98 1.1† 76 55 1 2 Note.—NR ϭ not reported. * A total of 137 of these patients received transarterial embolization before RF ablation. Tumor size, technical success rate, local recurrence rate, and major complication rate are composite data from de novo and recurrent HCC in this series. † Mean. Table 2 Details of Percutaneous Microwave Ablation in HCC among Cohort Studies with at Least 50 Patients (51–53) Survival Tumor Size (cm) Complete (%) Local Major No. of Child Class Ablation Recurrence Complications Study, Year Pts. (A/B/C) Mean Range (%) 3y 5y (%) (%) Dong et al, 2003 (51) 234 24/207/3 4.1 1.2–8.0 89* 66 57 7% 0% Liang et al, 2005 (52) 288 54/214/20 3.8 1.2–8.0 NR 72 51 8% NR Lu et al, 2001 (53) 50 16/30/4 2.7 0.8–6.4 94† 73 — 6% 0% Note.—NR ϭ not reported. * One session. † Two sessions. tromagnetic interference, only one RF nae can be simultaneously activated series showed no difference in complete electrode can be activated at one time, with MW ablation, potentially allowing ablation rate or survival between the which can lengthen procedure time in more rapid treatment of large or multi- two techniques in HCC averaging 2.6 medium and large lesions. Finally, the focal tumors (50). Grounding pads are cm in size, despite worse underlying grounding pads required for RF abla- not required. liver disease and more tumor multiplic- tion can occasionally cause skin burns. Three cohort studies of percutaneous ity in the MW ablation group (55). In These limitations have invited interest MW ablation in a mix of small to large contrast, a second unmatched series in alternative ablation modalities de- HCC demonstrated a complete ablation in small HCC showed better survival in scribed in the subsequent sections. rate of 89%–94%, local progression rate the RF ablation group (71% vs 49% at 3 of 6%– 8%, and 5-year survival rate of years), largely due to higher complica- Microwave Ablation 51%–57%, despite a predominance of tion and local recurrence rates with MW patients with Child class B disease (51– ablation (56). Microwave (MW) ablation uses high- 53). These results compare favorably The range of complications encoun- frequency electromagnetic energy to ag- with the results of RF ablation (Table 2) tered with MW ablation are the same as itate water molecules, producing frictional (51–53). with RF ablation, including hemor- heat and resultant coagulation necrosis. One randomized controlled trial (54) rhage, abscess, biliary tract injury, and Although both modalities function by compared MW ablation versus RF abla- tumor seeding. The rate of major com- tissue heating, MW ablation has several tion for small HCC in 72 well matched plication in most series varies from 0% advantages versus RF ablation. MW ab- patients. The complete ablation rates to 8%, similar to RF ablation. lation has a much broader zone of active were similar (89% for MW and 96% for The above-quoted studies of percuta- heating, leading to higher temperatures RF). Long-term survival was not re- neous MW ablation come from Asia, us- within the targeted zone in a shorter ported. ing a previous-generation 2450-MHz treatment time. The active heating of The only comparative survival data microwave system. A new generation of MW ablation is less affected by the heat- for MW versus RF ablation with percu- cooled-shaft 2450-MHz antennae prom- sink effect, improving tumor necrosis taneous technique come from retrospec- ise ablation volumes similar to the lat- adjacent to vessels (49). Multiple anten- tive, unmatched case series. One such est-generation RF ablation electrodes